In drug repurposing studies for COVID-19 studies, many suitable cheaper drugs and supplements have emerged from various studies as suitable candidates either as antivirals or to treat the cytokines storms associated with the disease or even other symptoms such as clotting issues. However many of these suitable candidates are often left on the shelves as the patents have expired or there are no patents on them hence the pharmaceutical giants are not motivated to have these further explored as they are unable to profit from them.
In the case of preventing cytokine storms in COVID19 patients, there have been many cheaper drugs options as suitable candidates for further study such as colchicine, melatonin and many more. In this article which is part of a series of articles that Thailand Medical News will be presenting to readers, we will be focusing on Melatonin as a suitable drug candidate to prevent Cytokine Storms in those infected with COVID-19.The big pharmaceuticals prefer to push expensive drugs like Tocilizumab that currently costs around 950 euros (US$1030) per injection and a patient might be needing like 2 to 3 injections whereas a bottle of decent 600mg of melatonin tablets might only cost about US$20. (We really hope that readers will truly appreciate our efforts and generously donate to sustain this website as the big pharma companies not only refuse to support our website but also want it shut!)
There has been a few studies to date that demonstrates the ability of melatonin to prevent inflammation and cytokine storms in COVID-19 patients.